Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Monday, May 20, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Monday, May 20, 2024 | Latest Paper
Subscribe Now

TRENDING:

David Renwick

A year later, none of the $1.5B for rare disease has flowed to patients

  • Further delays risk undermining the health and well-being of the very patients the National Strategy for Drugs for Rare Diseases was intended to assist.
Opinion | BY DAVID RENWICK | February 28, 2024
Health Minister Mark Holland speaks to reporters in West Block on Jan. 31. Bilateral agreements to transfer funds under the National Strategy for Drugs for Rare Diseases to increase drug access as well as diagnostic and screening capacity haven’t yet been signed, writes David Renwick. The Hill Times photograph by Andrew Meade

A year later, none of the $1.5B for rare disease has flowed to patients

Opinion | BY DAVID RENWICK | February 28, 2024
  • Further delays risk undermining the health and well-being of the very patients the National Strategy for Drugs for Rare Diseases was intended to assist.

A year later, none of the $1.5B for rare disease has flowed to patients

Opinion | BY DAVID RENWICK | February 28, 2024
  • Further delays risk undermining the health and well-being of the very patients the National Strategy for Drugs for Rare Diseases was intended to assist.
Health Minister Mark Holland speaks to reporters in West Block on Jan. 31. Bilateral agreements to transfer funds under the National Strategy for Drugs for Rare Diseases to increase drug access as well as diagnostic and screening capacity haven’t yet been signed, writes David Renwick. The Hill Times photograph by Andrew Meade
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu